NewGenIvf Group Ltd - IPO
NewGenIvf Group Ltd issued 5,175,000 public warrants and 3,145,000 private warrants, each exercisable at $11.50 per share, with the warrants expiring five years after the completion of the business combination.
Why this matters
NewGenIvf Group Ltd operates in the health services sector, focusing on miscellaneous health and allied services. The company has initiated an IPO, issuing 5,175,000 public warrants and 3,145,000 private warrants, each exercisable at $11.50 per share, with these warrants set to expire five years after the completion of the business combination. This move is part of their strategy to establish a digital asset portfolio, as evidenced by their recent engagement with OSL Digital Securities and plans to invest in the Solana network. The company's Class A Ordinary Shares are traded on The Nasdaq Capital Market under the symbol NIVF.